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Abstract
With the increasing complexity of external beam therapy “end-to-end” tests
are intended to cover every step from therapy planning through to follow-up in
order to fulfill the higher demands on quality assurance. As magnetic resonance
imaging (MRI) has become an important part of the treatment process, estab-
lished phantoms such as the Alderson head cannot fully be used for those tests
and novel phantoms have to be developed. Here, we present a feasibility study
of a customizable multimodality head phantom. It is initially intended for ion
radiotherapy but may also be used in photon therapy.
As basis for the anthropomorphic head shape we have used a set of patient
computed tomography (CT) images. The phantom recipient consisting of epoxy
resin was produced by using a 3D printer. It includes a nasal air cavity, a cranial
bone surrogate (based on dipotassium phosphate), a brain surrogate (based on
agarose gel), and a surrogate for cerebrospinal fluid (based on distilled water).
Furthermore, a volume filled with normoxic dosimetric gel mimicked a tumor.
The entire workflow of a proton therapy could be successfully applied to the
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phantom. CT measurements revealed CT numbers agreeing with reference val-
ues for all surrogates in the range from 2 HU to 978 HU (120 kV). MRI showed
the desired contrasts between the different phantom materials especially in T2-
weighted images (except for the bone surrogate). T2-weighted readout of the
polymerization gel dosimeter allowed approximate range verification.
Ein Prototyp fu¨r ein anthropomorphes multimodales (CT/MRT) Kopf-
phantom fu¨r End-zu-End-Tests in der Ionenstrahl-Therapie
Die ho¨here Pra¨zision der Strahlentherapie erfordert zugleich eine Verbesserung
der Qualita¨tssicherung, welche den gesamten Ablauf der Strahlentherapie ab-
decken muss. Da die Magnetresonanztomographie (MRT) eine zunehmend wichtige
Rolle spielt, ko¨nnen bisherige Phantome (wie der Alderson Kopf) dabei nur be-
grenzt eingesetzt werden. Diese Arbeit stellt eine Machbarkeitsstudie fu¨r ein
multimodales Kopfphantom dar, welches fu¨r die Ionenstrahl-Therapie konzip-
iert ist, aber auch in der Photonentherapie zum Einsatz kommen kann.
Die anthropomorphe Kopfform basiert auf dem Computertomographie (CT)-
Datensatz eines Patienten und wurde mithilfe eines 3D-Druckers aus Epoxidharz
geformt. Befu¨llt wurde das Phantom mit einem Knochensurrogat (Dikalium-
hydrogenphosphat-Lo¨sung), einem Gehirnsurrogat (Agarosegel) und einem Ven-
trikelsurrogat (destilliertes Wasser). Enthalten sind des Weiteren eine nasale
Luftkavita¨t sowie ein Dosimetriegel als Tumorsurrogat.
Das erstellte Phantom konnte den gesamten Prozess einer Bestrahlung mit Pro-
tonen durchlaufen. CT-Messungen des Phantoms ergaben mit den Referenzw-
erten natu¨rlicher Gewebe vergleichbare Hounsfield-Einheiten (2 HU bis 978 HU
bei 120 kV). Das Phantom lieferte auch in MRT-Messungen Kontraste, vor allem
in T2-gewichteten Bildern. Die Auswertung des Dosimetriegels mithilfe von
MRT ermo¨glichte eine Reichweitenbestimmung der Protonen.
Keywords: ion radiotherapy, ion beam therapy, proton therapy, treatment
planning, quality assurance, polymerization gel dosimeter, 3D dosimetry, rapid
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Ionenstrahl-Therapie, Partikeltherapie, Protonentherapie,
Bestrahlungsplanung, Qualita¨tssicherung, Dosimetriegel, 3D-Dosimetrie,
3D-Druck
1. Background
Over the last decade radiation therapy (RT) has achieved significantly higher
accuracy in dose delivery due to the improved image guidance and advanced
treatment delivery techniques. Consequently, adequate quality assurance be-
comes increasingly important, with a special focus on the integration of the
various techniques involved in the clinical workflow. This affects especially
the integration of MRI which is already utilized for target definition and is
widely expected to gain even more importance in image guidance. Recently, the
German Commission on Radiological Protection (Strahlenschutzkommission)
[1] recommended to test the entire chain of radiation therapy by system-wide
“end-to-end” tests. These tests are also claimed by the German Radiation Pro-
tection Ordinance (Strahlenschutzverordnung, StrSchV) [2] while the Standards
Committee for Radiology (Normenausschuss Radiologie, NAR) is working out
corresponding standards for the coming years.
Such tests call for phantoms able to represent the patient in a number of essen-
tial radiological aspects, such as the contrasts from different imaging modalities
for diagnosis, target delineation, and treatment simulation. Furthermore, phan-
toms should allow to test different techniques and tools for patient fixation and
dose delivery.
The Alderson head is most likely the best known example for a phantom pro-
viding anthropomorphic structures with realistic contrasts in CT. Being based
on bony material and polymers, it cannot however, be used with MR imag-
ing. Additionally, it hardly allows three-dimensional dosimetry and is limited
to pointwise dose measurements (by inserting 1D dosimeters such as ion cham-
bers) and two-dimensional measurements (by inserting films into designated
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slots).
It is therefore desirable to develop multimodality phantoms providing not only
contrasts in both CT and MRI but also opening the possibility of a more flexible
dosimetry. In this article we present a prototype of a phantom which has been
based on a head shaped recipient with compartments for surrogates of brain,
bone, and ventricles. In the target volume, polymerization gel was placed [3].
During our study, the phantom underwent CT and MR imaging followed by
treatment planning and proton irradiation. Subsequently, range verification
was performed by an MRI readout of the polymerization gel dosimeter in the
target volume.
2. Material and Methods
2.1. Phantom Recipient
The phantom recipient was produced by means of 3D printing using epoxy
resin as the printing material. 3D printing allows the production of stable ob-
jects of almost any shape. One of many possible applications in the future might
be the production of individualized phantoms according to patient geometries
[4].
The phantom recipient was composed of two separated parts as a compromise
between anatomic reality and geometric shapes that are easy to handle (e.g. for
filling with tissue surrogates, Fig. 1) without loss of generality for the approach
itself. The anthropomorphic outer shape was modelled by segmenting a head
outline from a CT-dataset using the MITK software (version 2012.12.00, seg-
mentation tool “Add”) [5]. A simplified nasal cavity was added and a solid chin
part made from printed epoxy resin. The second part of the phantom consists
of a system of inner cylinders constructed using Autodesk Inventor Professional
2013 [6] to house the tissue surrogates and the polymerization gel dosimeter in
the target volume. After printing, both parts were combined and nested. Access
to the inner compartments was assured by holes in the neck region. Compart-
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ment D (Fig. 1) was printed separately and can be exchanged easily.
Figure 1: The prototype head phantom. Left part: the phantom fixated with a thermoplastic
mask. Middle: CT image cross section of the phantom (A: cranial bone surrogate, B: brain
tissue surrogate, C: cerebrospinal fluid surrogate, D: polymerization gel dosimeter). Right
part: inner cylindrical structure set.
2.2. Phantom Materials
We restricted our study to the following, most essential materials found in
the human head.
2.2.1. Bone Surrogate
Compartment A of the phantom (Fig. 1) contains a surrogate representing
cranial bone using a solution of 1250 g dipotassium phosphate (K2HPO4) in one
liter of distilled water. Solutions of dipotassium phosphate allow the adjustment
of electron densities comparable to those of bone for CT. Furthermore, their
chemical composition is similar to bony tissues (esp. “ribs 10th” from [7])
which is advantageous for realistic mimicking of photon and ion interaction
processes with the material. However, the ratio of carbon and oxygen in polymer
surrogates cannot be exactly the same as for tissue, e.g. the bone liquid contains
no carbon in contrast to real bone (Tab. 1). This is tolerable since the effective
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atomic number and the I-value of carbon and oxygen are similar. An advantage
of the liquid bone surrogate is the easy positioning in the phantom recipient with
minimal air inclusions and the easy removal or replacing. Heating the water to
50◦C helps to dissolve the elevated concentration of dipotassium phosphate in
water.
Table 1: Density ρ, atomic composition, relative electron density to water ρe− , effective atomic
number Zeff , and mean excitation potential I of the investigated materials. (
a[8])
Surrogate ρ [
g
cm3
] H O C P K ρ
e− Zeff I [eV]
Bone liquid 1.53 0.054 0.603 - 0.097 0.246 1.308 12.82 104.5
Brain gel/agarose gel 0.96 0.109 0.024 0.867 - - 0.958 7.42 75.4
Ventricle/water 1.00 0.112 - 0.888 - - 1.000 7.45 75.3
Soft bone/printing material 1.21 n/a n/a n/a n/a n/a 1.181 9.28 n/a
Tumor volume/dosimetric gel 1.05a 0.104a 0.105a 0.767a - - 1.021 7.30 74.5
2.2.2. Brain Surrogate
Compartment B (Fig. 1) represents the brain tissue and contains a gel made
from agarose powder and distilled water. By adjusting the concentration of
agarose in gels, T2 and to a smaller extent T1 MR relaxation times can be mod-
ified. On the other hand, agarose hardly influences the electron or mass density
and consequently the CT contrast will remain largely the same within different
agarose gels (Fig. 2). Due to the polysaccharide polymer material, agarose also
features a tissue equivalent composition and is therefore an adequate surrogate
to mimic various soft tissues corresponding to good MRI but poor CT contrasts.
In general, we found that agarose concentrations of 1-6 % are feasible to solute.
In this study, a brain surrogate was made by heating 105.25 g of agarose powder
in 2000 g distilled water (corresponding to a concentration of 5 % agarose). The
mixture from agarose and distilled water needs to boil for at least one minute
and can be drawn into the recipient by using a vacuum pump.
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Figure 2: CT-numbers of agarose gels with a concentration up to 6 % for a series of tube
voltages and additional CT contrast agent. Adding a high Z CT contrast agent such as Barilux
(based on bariumsulfate) opens the possibility to vary CT and MR contrasts independently.
CT contrast agents hardly influence the T1 and T2 contrast. Vice versa, concentrations of
MR contrast agents (e.g. gadolinium) of a few mmol/L would hardly influence CT contrasts.
2.2.3. Ventricle Surrogate
The cerebrospinal fluid in the ventricles is very similar to water. For that
reason, distilled water was filled into compartment C (Fig. 1) which additionally
provides a standard for MR as well as for CT imaging.
2.2.4. Tumor Surrogate/Polymerization Gel Dosimeter
While the previous materials were chosen for achieving realistic contrasts
in CT and MR imaging, the polymerization gel dosimeter in compartment D
(Fig. 1) mainly served the range verification. For this study, a BANG R©3-
Pro
TM
Gel Dosimeter Kit bought from MGS was prepared by following the
instructions given by the manufacturer. During irradiation, water molecules
contained in the gel start dissociating into free radicals which induce the poly-
merization of monomers present in the gel. This dose dependent polymerization
reduces the mobility of free water molecules causing a change in the T2 relax-
ation time of the irradiated gel which can be detected in 3D by T2-weighted MR
acquisitions. Besides the dosimetry purpose, the gel also represents a further
soft tissue contrast similar to ICRU 44 brain tissue [8].
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Soft tissue contrast, the easy incorporation of the dosimeter in the anthropomor-
phic shape, and the possibility to perform 3D dosimetry were the main reasons
for choosing a polymerization gel dosimeter, despite its current limitations for
proton and ion dosimetry.
2.2.5. Soft Bone/Printing Material
The printing material forms the outermost layer of the phantom as well as
the separation layers between the surrogates and a massive block in the chin
region. It is an artificial epoxy resin and being a polymer with a density of
1.21 g/cm3 (cured), it also serves as a soft bone surrogate.
3. Experiments
The head phantom filled with the tissue surrogates was screwed to a wooden
board using a thermoplastic mask (Fig. 1). Subsequently, the head phantom
followed the workflow process of a typical proton radiotherapy treatment course
with pre-treatment imaging via CT and MR, treatment planning on CT images,
delivery, and range verification by using the MR readout of the polimerization
gel dosimeter.
3.1. Pre-treatment MR Imaging
The head phantom was positioned in the 12-channel head coil of a Siemens
1.5 T MAGNETOM Avanto scanner in order to acquire the pre-treatment MR
image. T1- and T2-weighted images (4 mm slices) were acquired using a flash
2D (TR=110 ms, TE=4.8 ms) and a turbo spin echo (TR=3500 ms, TE=88 ms)
sequence, respectively. The phantom was removed from the wooden board and
the immobilization mask to fit into the used head coil. The obtained images
were used for analyzing the similarity between the phantom’s and real tissues’
MR contrasts as well as for the comparison of the polymerization gel dosimeter
8
before and after the irradiation.
3.2. Material Characterization in a Dual Energy CT Scanner
The immobilized head phantom was imaged in a dual energy CT scanner
(Siemens Somatom Definition Flash) at tube voltages of 80 kVp and 140 kVp/Sn
(higher spectrum is hardened by a tin filter). Tube currents (eff. mAs) were set
to 220 mAs (80 kVp)/85 mAs (140 kVp/Sn) with a default pitch of 0.6 and a ro-
tation time of 1 s. 3 mm slice images were reconstructed with a D30 kernel. Both
image stacks were further processed by a dedicated algorithm [9] to calculate an
electron density and effective atomic number image stack. Electron density and
effective atomic number were evaluated to explore tissue equivalence. To obtain
the CT numbers, the images were processed by “R” [10] using the “oro.dicom”
package. Gray values were analyzed in eleven slices using the circular VOIs
shown in Fig. 3.
Figure 3: VOI selection in the transversal CT plane to evaluate image values (HU, ED, Zeff)
prediction of single and dual energy CT for the investigated phantom materials.
9
3.3. Tumor Localization and Treatment Planning
CT imaging for treatment planning was acquired with the Siemens Bio-
graph mCT operated in clinical routine for treatment planning at the Heidel-
berg Ionbeam-Therapy Center (HIT).1 Image acquisition was done with 120 kVp
and the standard planning protocol (eff. mAs of 300, 3 mm slice thickness, H40
reconstruction kernel, 310 mm FOV). The CT number conversion to relative
stopping-power ratio for ions was assured by a standard stoichiometric calibra-
tion [11].
A target volume of 5x5x3.5 cm3 was defined for an irradiation at a horizontal
beamline at HIT with 2 Gy physical proton dose. To allow subsequent moni-
toring of the steep proton dose fall off in the polymerization gel dosimeter, the
irradiation was planned such that the dose maximum reached up to the center of
the gel (Fig. 4). Plan optimization was performed with the treatment planning
system syngo R© RT Planning VB10.
3.4. Phantom Positioning and Treatment
Crosshairs on the basis of the single energy CT scanner’s lasers were sketched
onto the phantom. Because the single energy CT scanner delivered the dataset
for treatment planning, the phantom was positioned on the basis of those
crosshairs at the horizontal irradiation place. Irradiation was performed at HIT
using active raster scanning of protons in 28 iso-energy slices (between 87.53
and 140.97 MeV corresponding to a range between 6.1 and 14.3 cm in water) to
cover a volume of 5x5x3.5 cm3. The dose rate was approximately 3.0 (8.2) Gyl·min
including (without) spill pauses.
1Dual CT used for material characterization (sec. 3.2) only as it is not yet part of clinical
routine.
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Figure 4: Planning CT including PTV (pink) and isodose lines. An overshoot is clearly seen
due to a tungsten pin attached to the mask which was used to simulate the impact of a dental
implant on the dose distribution.
11
3.5. Range Verification with the MR readable polymerization gel dosimeter
For range verification, the polymerization gel dosimeter in compartment D
(Fig. 1) was read out using a T2-weighted turbo spin echo sequence (TR=4120 ms,
TE=87 ms, slice thickness 1.5 mm, 1.28 pixel/mm). Only the irradiated part of
the polymerization gel dosimeter and its immediate surrounding were imaged.
The MR acquisitions were saved as a DICOM data set and the profile in Fig. 5
was obtained by processing the pixel values by the “R” software [10]. To do so,
the brightness profiles in the irradiated part along the beam axis were super-
posed and averaged. Two lines were adapted to this average profile and their
intersection was determined.
We did not perform a registration of the MR acquisitions with the treatment
Figure 5: Left part: T2-weighted MR image; the distal beam edge is hardly visible (lower
signal intensities in the irradiated right part of the polymerization gel dosimeter). Right part:
mean MR signal profile in the polymerization gel dosimeter along the proton beam axis in
the area of the SOBP; the distal edge is more obvious as this curve is averaged across x. The
dashed line is parallel to the distal edge and passes through the central point of the innermost
compartment. Thus, it represents the planned edge of the dose maximum. The intersection
of the fitted red lines represents the measured edge of the dose maximum which is positioned
about 0.3 mm right of the planned edge.
plan but we compared the positions in the gel relative to the central point of
compartment D (Fig. 1) which was possible since pixel size and compartment
size were known.
12
4. Results
4.1. MR Imaging
Fig. 6 shows a T1- and a T2-weighted transversal cross section of the phan-
tom. Contrasts are more pronounced in T2-weighted acquisitions and materials
can be distinguished except for the printing material and air whose signal in-
tensities are both very low. The brain surrogate in compartment B shows a
low signal in both T1- and T2-weighting and reacts therewith similar to muscle
tissue. The polymerization gel dosimeter in compartment D can be regarded as
a soft tissue surrogate and shows a rather high signal in the T2-weighted acqui-
sition and a low signal in the T1-weighted image - this is typical for liquids and
water (see also the ventricle surrogate in compartment C). The bone surrogate
(A) does not meet the requirements of realistic MR signal intensities as it shows
high signal intensity in both weightings due to its aqueous nature (Fig. 6).
Figure 6: T1- (left) and T2-(right) weighted transversal cross section of the head phantom.
A: cranial bone surrogate, B: brain tissue surrogate, C: cerebrospinal fluid surrogate, D:
polymerization gel dosimeter.
4.2. Material Characterization
CT images of the dual energy CT (see 3.2) and the single energy planning
CT scanner (see 3.3) were registered with a mutual information algorithm im-
plemented in the planning system “VIRTUOS” at DKFZ. Tab. 2 summarizes
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the mean and standard deviations of the phantom materials’ CT numbers, elec-
tron density, and effective atomic number.
Table 2: Measured CT numbers, relative electron densities and effective atomic numbers.
Material CT no80kV [HU] CT no120kV [HU] CT no140kV [HU] ρe− Zeff
Ventricle/water 16 ± 23 2 ± 7 5 ± 17 1.000 ± 0.012 7.7 ± 0.4
Brain gel/agarose gel 45 ± 24 24 ± 8 24 ± 16 1.015 ± 0.011 7.9 ± 0.3
Soft bone/printing material 357 ± 24 286 ± 15 243 ± 16 1.191 ± 0.011 9.4 ± 0.2
Tumor volume/dosimetric gel 52 ± 25 41 ± 7 43 ± 18 1.039 ± 0.012 7.6 ± 0.4
Bone liquid 1298 ± 35 978 ± 24 774 ± 18 1.54 ± 0.013 12.2 ± 0.1
4.3. Gel read out
Fig. 5 (left part) visualizes the T2-weighted MR acquisitions of the polymer-
ization gel dosimeter taken after irradiation. The brightness profile (Fig. 5, right
part) shows a significant signal drop from left to right.
5. Discussion
5.1. Imaging Contrasts and Material Properties
CT numbers of the investigated surrogates were found to be comparable to
simulated reference values found in [12] (bone solution to mandible: max. deviation
35 HU; brain surrogate and agarose gel to reference brain tissue: max. deviation
13 HU; printing material to spongiosa: max. deviation 34 HU). Electron densi-
ties are consistent to the reference electron densities of the corresponding tissues
and deviate by maximum 0.04 (absolute value). Effective atomic numbers agree
within 0.2-1.1 (absolute values) compared to reference values [13] (Tab. 3).
MR acquisitions showed signal intensities of the soft tissue surrogates that are
qualitatively similar to the natural equivalents’ intensities. Improvements of the
phantom could therefore rather focus on more realistic and further differentiated
materials for MR imaging. The excellent MR based soft tissue distinction is used
for target and normal structure delineation in RT and should be provided in
a future “end-to-end” test phantom. Additionally, a solid bone surrogate with
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Table 3: Reference values of three tissues taken from [13], [12]. These tissues show compa-
rable attributes to the materials investigated in this work. Please mind that effective atomic
numbers were calculated with a slightly different exponent of m=3.5 in [12] as compared to
this work (m=3.1, [9]) and are therefore larger than measured Zeff in this work.
Material ρe− Zeff CT no80kV [HU] CT no140kV [HU]
Brain 1.035 7.65 43 37
Spongiosa 1.150 10.49 339 209
Mandible 1.577 13.16 1326 809
no MR signal would be desirable to test e.g. matching algorithm. It could be
realized for example with gypsum or even with the printing material itself. By
doing the latter, a more realistic anatomy would be possible by directly printing
the bone matrix of the patient specific CT data plus additional compartments
for soft tissue.
5.2. Range Verification
The brightness profile in the polymerization gel dosimeter does not show a
sharp distal edge of the spread out Bragg peak (SOBP) (Fig. 5, right), which is
likely due to partial volume detection [14], i.e. the dose in the Bragg-peak region
can be misjudged due to averaging over the voxel size. In addition, quenching
can occur for high LET protons [15].
Our method to compare the planned and the measured dose edge has to be
improved for future applications as it cannot be applied to patients with a
considerably complexer geometry; the registration of treatment plan and MR
images would therefore be most preferable.
Furthermore, the determination of the distal edge from the measured data is
subject to an uncertainty of approximately 2 mm in the position of the com-
partment center in the MR acquisitions as well as due to procedure of fitting
two lines to the profile in Fig. 5. In addition, degradation of the distal edge oc-
curs due to the impact of the tungsten pin (compare Fig. 4). Nevertheless, the
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planned (dashed line in Fig. 5) and the measured range (intersection of the fitted
lines in Fig. 5) agree within this uncertainty, stressing that range verification us-
ing polymerization gel dosimeters is principally possible. Future studies should
also exploit 3D dose readout for quantitative dose verification, which requires
amongst others a reliable calibration curve made from a series of polymarization
gel dosimeters of identical geometry having been irradiated with different doses.
6. Conclusions
We present a prototype of a head shaped multimodality phantom for patient
specific “end-to-end” tests including CT and MR imaging as well as a target
volume providing range verification via gel dosimetry. We believe such phan-
toms to be increasingly necessary in the future due to the higher requirements
for quality assurance in radiotherapy.
The phantom was found to be able to follow the entire workflow of an ion radia-
tion. CT and MR contrast matched tissue values. Furthermore, the polimeriza-
tion gel provided range verification with MRI. This phantom was a prototype
study towards patient specific “end-to-end” tests in radiotherapy. Further de-
velopments should focus on more realistic anatomical matrices and more differ-
entiated materials for further exploiting the excellent soft tissue contrast offered
by MRI. Additionally, range verification might be extended to actual dose ver-
ification.
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